Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-20

Clinical Trial Update: V-IMMUNE® for Immune Thrombocytopenia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial of V-IMMUNE for immune thrombocytopenia is actively recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • V-IMMUNE

Snippet

Sponsor: On Pharma Importadora, Exportadora e Distribuidora de Medicamentos LTDA. | Conditions: Immune Thrombocytopenia (ITP) | Phase 3 | Status: RECRUITING